| abstract |
The invention relates to methods for predicting the benefit of chemotherapy. The invention predicts the benefit of chemotherapy based on the analysis of biomarker expression, for example, the transcriptional analysis of RNA-based biomarkers from a tumor sample. Expression data from biomarkers can be combined with clinical variables, such as tumor size and nodal status, to generate a profile that predicts the benefit of including chemotherapy in a therapeutic decision. |